close

Mergers and Acquisitions

1 29 30 31 32
Number of results: 629
Date Acquired company Acquiring company Amount Related
2011-05-19 Nycomed (Switzerland) Takeda Pharmaceutical (Japan) € 9.6 billion

Gastroenterology
Respiratory diseases
Inflammatory diseases
Pain
Osteoporosis
Tissue management
OTC products

2011-05-17 Advanced BioHealing (USA) Shire (UK - USA) $750 million in cash

Regenerative medicine

2011-05-09 Elan Drug Technologies (formulation and manufacturing business unit of Elan – Ireland) Alkermes (Ireland - USA) $960 Million (€668.7 million)

CNS
Pharmaceutical development

2011-05-02 Cephalon (USA) Teva Pharmaceuticals (Israel) $6.8 billion (€10.1 billion)

Specialty pharma
CNS diseases
Cancer - Oncology
Respiratory diseases

2011-05-02 Nordic Vaccine (Denmark) Isconova (Sweden) SEK 4,032,228 (€ 446 600)

Vaccines

2011-04-27 Lab Research (Canada) CIT Safety & Health Research Laboratories (CIT) (France) undisclosed

CRO

2011-04-12 LAB Research (Canada) CIT (France) undisclosed

CRO
Preclinical research

2011-04-11 Biophausia (Sweden) Medivir (Sweden) undisclosed

Specialty pharma

2011-04-06 Astex Therapeutics (UK) SuperGen (USA) $55 million (€38.3 million)

Cancer Oncology

2011-03-24 Amgen’s biopharmaceutical development and manufacturing facility in Fremont, California (USA) Boehringer Ingelheim (Germany) undisclosed

Production
Manufacturing

2011-03-22 Zhejiang Tianyuan (China) Novartis (Switzerland) undisclosed

Vaccines

2011-03-15 Theragenics (USA) Eckert & Ziegler Strahlen- und Medizintechnik (Germany) $74 million
2011-03-15 PVT (Germany) Roche (Switzerland) € 65 million and up to € 20 million upon reaching performance-related milestones.

clinical diagnostics

2011-03-08 Crucell (The Netherlands) Johson&Johnson - J&J (USA) €1.75 billion

Vaccines
Infectious diseases
Bioproduction

2011-03-02 veterinary business of Riemser Arzneimittel (Germany) Ecuphar (Belgium)

Veterinary medicine

2011-02-28 Avogadro (France) Amatsi (France) undisclosed

Drug development services

2011-02-25 Cellerix (Spain) Tigenix (Belgium)

stem cell
regenerative medicine
cell therapy

2011-02-24 Lancaster Laboratories (USA) Eurofins Scientific (France) approximately $ 200 million

Pharmaceutical product testing services and cGMP Quality Control

2011-02-22 iNovia (Sweden) Kancera (Sweden) undisclosed

services

2011-02-21 Prostrakan (UK) Kyowa Hakko Kirin (Japan) £ 292 million(€ 345,3 million) specialty pharma